Literature DB >> 17207472

Persistent disruption of a traumatic memory by postretrieval inactivation of glucocorticoid receptors in the amygdala.

Sophie Tronel1, Cristina M Alberini.   

Abstract

BACKGROUND: Posttraumatic stress disorder (PTSD) is characterized by acute and chronic changes in the stress response, which include alterations in glucocorticoid secretion and critically involve the limbic system, in particular the amygdala. Important symptoms of PTSD manifest as a classical conditioning to fear, which recurs each time trauma-related cues remind the subject of the original insult. Traumatic memories based on fear conditioning can be disrupted if interfering events or pharmacological interventions are applied following their retrieval. METHODS AND
RESULTS: Using an animal model, here we show that a traumatic memory is persistently disrupted if immediately after its retrieval glucocorticoid receptors are inactivated in the amygdala. The disruption of the memory is long lasting and memory retention does not re-emerge following strong reminders of the conditioned fear.
CONCLUSIONS: We propose that a combinatorial approach of psychological and pharmacological intervention targeting the glucocorticoid system following memory retrieval may represent a novel direction for the treatment of PTSD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207472      PMCID: PMC1978220          DOI: 10.1016/j.biopsych.2006.09.009

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  64 in total

Review 1.  Animal models of relevance to PTSD.

Authors:  A M Rasmusson; D S Charney
Journal:  Ann N Y Acad Sci       Date:  1997-06-21       Impact factor: 5.691

2.  Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation.

Authors:  L M Shin; S M Kosslyn; R J McNally; N M Alpert; W L Thompson; S L Rauch; M L Macklin; R K Pitman
Journal:  Arch Gen Psychiatry       Date:  1997-03

3.  Glucocorticoid receptor agonist and antagonist administration into the basolateral but not central amygdala modulates memory storage.

Authors:  B Roozendaal; J L McGaugh
Journal:  Neurobiol Learn Mem       Date:  1997-03       Impact factor: 2.877

4.  The effects of the dopamine D1 receptor antagonist SCH23390 on memory reconsolidation following reminder-activated retrieval in day-old chicks.

Authors:  Joanne M Sherry; Matthew W Hale; Simon F Crowe
Journal:  Neurobiol Learn Mem       Date:  2005-03       Impact factor: 2.877

5.  Corticosteroid receptor antagonists are amnestic for passive avoidance learning in day-old chicks.

Authors:  C Sandi; S P Rose
Journal:  Eur J Neurosci       Date:  1994-08-01       Impact factor: 3.386

Review 6.  The psychobiological basis of posttraumatic stress disorder.

Authors:  C Grillon; S M Southwick; D S Charney
Journal:  Mol Psychiatry       Date:  1996-09       Impact factor: 15.992

Review 7.  Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  R N Brogden; K L Goa; D Faulds
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

8.  Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats.

Authors:  M S Oitzl; M Fluttert; W Sutanto; E R de Kloet
Journal:  Eur J Neurosci       Date:  1998-12       Impact factor: 3.386

9.  Dose-response relationships of RU 486.

Authors:  O Heikinheimo; R Kekkonen
Journal:  Ann Med       Date:  1993-02       Impact factor: 4.709

10.  A correlative study of RU38486 biopotency and competition with [3H]dexamethasone for receptors in the rat central nervous system.

Authors:  B D Allen; W Sutanto; M T Jones
Journal:  J Steroid Biochem       Date:  1988       Impact factor: 4.292

View more
  33 in total

1.  Remembered for forgetting.

Authors:  Cassandra Willyard
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

2.  Healing anxiety disorders with glucocorticoids.

Authors:  Carmen Sandi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

Review 3.  Transcriptional Regulation Involved in Fear Memory Reconsolidation.

Authors:  Xu Wang; Min Li; Haitao Zhu; Yongju Yu; Yuanyuan Xu; Wenmo Zhang; Chen Bian
Journal:  J Mol Neurosci       Date:  2018-05-23       Impact factor: 3.444

Review 4.  Pharmacological treatment of PTSD - established and new approaches.

Authors:  Thomas Steckler; Victoria Risbrough
Journal:  Neuropharmacology       Date:  2011-06-29       Impact factor: 5.250

Review 5.  Stress modulation of reconsolidation.

Authors:  Irit Akirav; Mouna Maroun
Journal:  Psychopharmacology (Berl)       Date:  2012-10-06       Impact factor: 4.530

Review 6.  Translational Approaches Targeting Reconsolidation.

Authors:  Marijn C W Kroes; Daniela Schiller; Joseph E LeDoux; Elizabeth A Phelps
Journal:  Curr Top Behav Neurosci       Date:  2016

7.  Forebrain glutamatergic, but not GABAergic, neurons mediate anxiogenic effects of the glucocorticoid receptor.

Authors:  J Hartmann; N Dedic; M L Pöhlmann; A Häusl; H Karst; C Engelhardt; S Westerholz; K V Wagner; C Labermaier; L Hoeijmakers; M Kertokarijo; A Chen; M Joëls; J M Deussing; M V Schmidt
Journal:  Mol Psychiatry       Date:  2016-05-31       Impact factor: 15.992

Review 8.  Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies.

Authors:  Charles Finsterwald; Cristina M Alberini
Journal:  Neurobiol Learn Mem       Date:  2013-10-07       Impact factor: 2.877

9.  Glucocorticoid receptor antagonism disrupts the reconsolidation of social reward-related memories in rats.

Authors:  E J Marijke Achterberg; Viviana Trezza; Louk J M J Vanderschuren
Journal:  Behav Pharmacol       Date:  2014-06       Impact factor: 2.293

10.  Stress-dependent opioid and adrenergic modulation of newly retrieved fear memory.

Authors:  Allen M Schneider; Peter E Simson; Caitlin M Daimon; Jakob Mrozewski; Nicholas M Vogt; John Keefe; Lynn G Kirby
Journal:  Neurobiol Learn Mem       Date:  2013-11-27       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.